<DOC>
	<DOCNO>NCT00164372</DOCNO>
	<brief_summary>The purpose study test whether six-session behavioral intervention HIV HCV seronegative injection drug user effective reduce sexual injection risk behavior could lead primary HIV HCV infection .</brief_summary>
	<brief_title>Behavioral Intervention HIV HCV-Uninfected Injection Drug Users</brief_title>
	<detailed_description>CIDUS III/DUIT five-city ( Baltimore , Chicago , Los Angeles , New York , Seattle ) randomize control trial develop evaluate efficacy six-session behavioral intervention HIV HCV uninfected injection drug user age 15 30 year . The primary goal intervention : 1. decrease share use syringe injection paraphernalia , 2. decrease sexual risk behavior associate HIV HCV infection , 3. decrease incidence hepatitis C virus ( HCV ) infection . The intervention arm consist six small-group train skills-building session teach reinforce peer education activity around decrease sex injection risk behavior HIV HCV infection . In fifth session , participant practice peer education around sex injection risk behavior within community . The control arm consist six video discussion session control attention . Prior study enrollment , participant arm receive HIV HCV test client-centered pre- post-test counseling also control demand risk reduction information . Behavioral assessment ( audio computer assist self interviewing ) blood draw ( serologic test ) occur baseline , 3 6 month follow-up . 3285 participant complete baseline visit , 1564 test HIV HCV seronegative return test result make eligible enroll intervention trial . Of eligible participant , 854 randomize trial . 606 591 return 3 6 month follow-up assessment , respectively , 712 participant complete least one follow-up visit .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>age 1530 year old selfreported illicit drug injection within past 6 month live geographic region study plan stay &gt; 12 month willing provide blood sample serologic test willing provide basic contact information followup able communicate English participate pilot study previously enrol trial concurrently participate HIV HCV intervention trial test HIV HCV seronegative baseline</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>IV Drug user</keyword>
	<keyword>HIV</keyword>
	<keyword>hepatitis C virus</keyword>
	<keyword>HIV Seronegativity</keyword>
</DOC>